A decade of genome-wide gene expression profiling in acute myeloid leukemia: flashback and prospects

Research output: Contribution to journalArticleAcademicpeer-review

80 Citations (Scopus)


The past decade has shown a marked increase in the use of high-throughput assays in clinical research into human cancer, including acute myeloid leukemia (AML). In particular, genome-wide gene expression profiling (GEP) using DNA microarrays has been extensively used for improved understanding of the diagnosis, prognosis, and pathobiology of this heterogeneous disease. This review discusses the progress that has been made, places the technologic limitations in perspective, and highlights promising future avenues. (Blood. 2009;113:291-298)
Original languageUndefined/Unknown
Pages (from-to)291-298
Number of pages8
Issue number2
Publication statusPublished - 2009

Cite this